ACM Shanghai Receives CSRC Approval for Private Offering of Up to 44.1 Million Shares, Targeting Proceeds of RMB 4.5 Billion
ACM Research Inc.'s operating subsidiary, ACM Research (Shanghai), Inc., has received significant regulatory approval from the China Securities Regulatory Commission (CSRC) for its proposed private offering of ordinary shares. Announced on June 28, 2025, this approval allows ACM Shanghai to proceed with the offering within the next 12 months. The private offering, initially disclosed in January 2024, permits the issuance of up to 10% of ACM Shanghai's share capital, now updated to 44.1 million ordinary shares. This move is expected to generate gross proceeds of up to RMB 4.5 billion, approximately $625 million, reflecting the company's recent exercise of employee stock options. There is no indication that any other organizations are involved in this specific offering.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ACM Research Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-25-024198), on June 30, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。